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Abstract
Background: Moxibustion (a type of Chinese medicine which involves burning a herb close to the skin) has been
used to correct a breech presentation. Evidence of effectiveness and safety from systematic reviews is encouraging
although significant heterogeneity has been found among trials. We assessed the feasibility of conducting a
randomised controlled trial of moxibustion plus usual care compared with usual care to promote cephalic version
in women with a breech presentation, and examined the views of women and health care providers towards
implementing a trial within an Australian context.
Methods: The study was undertaken at a public hospital in Newcastle, New South Wales, Australia. Women at
34-36.5 weeks of gestation with a singleton breech presentation (confirmed by ultrasound), were randomised to
moxibustion plus usual care or usual care alone. The intervention was administered over 10 days. Clinical outcomes
included cephalic presentation at birth, the need for ECV, mode of birth; perinatal morbidity and mortality, and
maternal complications. Feasibility outcomes included: recruitment rate, acceptability, compliance and a sample
size for a future study. Interviews were conducted with 19 midwives and obstetricians to examine the acceptability
of moxibustion, and views on the trial.
Results: Twenty women were randomised to the trial. Fifty one percent of women approached accepted
randomisation to the trial. A trend towards an increase in cephalic version at delivery (RR 5.0; 95% CI 0.7-35.5) was found
for women receiving moxibustion compared with usual care. There was also a trend towards greater success with
version following ECV. Two babies were admitted to the neonatal unit from the moxibustion group. Compliance with
the moxibustion protocol was acceptable with no reported side effects. Clinicians expressed the need for research to
establish the safety and efficacy of moxibustion, and support for the intervention was given to increase women’s
choices, and explore opportunities to normalise birth. The sample size for a future trial is estimated to be 381 women.
Conclusion: Our findings should be interpreted with caution as the study was underpowered to detect statistical
differences between groups. Acceptance by women and health professionals towards moxibustion suggest further
research is warranted.
Trial Registration: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12609000985280
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Background
Three to four percent of babies at full term are in a
breech presentation [1]. To reduce the incidence of
babies in a breech presentation external cephalic version
(ECV) and postural management have been used to cor-
rect the presentation prior to term. Whilst ECV at term
has been shown to be successful [2] ECV between 32-
34 weeks is not successful and there is insufficient data
regarding effectiveness of ECV between 34 and 36 weeks
[3]. Recently reported findings from the Early ECV trial
at 24-35 weeks versus 37 or more weeks reported an
increased likelihood of cephalic presentation at birth but
no reduction in the rates of caesarean delivery, or in the
risk of preterm birth [4]. ECV may not be acceptable to
all women [5], and some women express a preference for
a vaginal birth [6-8], therefore there remains a need to
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care.
Traditional Chinese medicine (TCM) has a tradition of
using moxibustion for postural management. This method
dates back about 1300 years [9] and is commonly used in
primary healthcare systems in East Asia [10]. Moxibustion
is a technique which generates heat by burning a herbal
preparation containing Artemisia vulgaris (mug-wort),
applied close to the skin until it produces hyperaemia
from local vasodilatation. To promote cephalic version,
moxibustion is applied to the acupuncture point bladder
67 (BL67 (located on outer corner of the fifth toenail)).
Treatment regimes vary with no consensus on the best
regime, however applying moxibustion for 15-20 minutes,
from one to ten times daily up to 10 days is common in
clinical practice [11]. The general mechanism of moxibus-
tion is proposed to be a combination of thermal (infrared
radiation) and pharmacological action of the materials
used [12,13]. Moxibustion sticks have been shown to emit
primarily long-wavelength infrared radiation (IR-C) indi-
cating that moxibustion mainly affects the superficial skin,
where heat receptors are located [13]. Due to the limited
skin penetration of IR-C moxibustion sticks thermal
effects on internal organs are more likely due to arise from
reflex mechanisms [14].
Evidence of the clinical effectiveness of moxibustion
h a sb e e ns u m m a r i s e di nt w os y stematic reviews [15,16].
In the most recent review an increased rate of cephalic
version was found in the moxibustion group compared
to the control group (Relative Risk (RR), 1.36, 95% confi-
dence interval, 1.17-1.58) [15]. There were no significant
differences in any adverse clinical outcomes between
groups, although numbers were small. Whilst these
results were encouraging, there was significant heteroge-
neity between trials, and further high quality research is
needed. Evaluating unfamiliar interventions from differ-
ent cultural contexts require preliminary evaluation
through feasibility studies. However, limited studies of
moxibustion have been successfully implemented for
breech presentation in Western maternity settings, and
the influence of cultural unacceptability resulting in poor
compliance and early stopping was evident in at least one
trial of moxibustion [17]. Recently two studies reported
positive experiences from women on using moxibustion,
with high compliance, and few problems [5,18]. However
the views of health care providers identify a need for
further research to demonstrate clinical and cost effec-
tiveness [5]. We report on the findings from a feasibility
study of moxibustion compared with usual care in a ran-
domised controlled trial (RCT) for women with a breech
presentation. We also examined the acceptability of
implementing a trial within an Australian context among
pregnant women and their health care providers.
Methods
This study was conducted at the John Hunter Hospital, a
public hospital in Australia. Human ethics approval was
obtained from the Hunter New England Human
Research Ethics Committee of Hunter New England
Health (EC00403) to conduct the clinical trial and inter-
views with health professionals. Women were eligible if
they were aged greater than 18 years, at 34-36.5 weeks of
gestation with a singleton breech presentation (confirmed
by ultrasound), and normal fetal biometry. Early inter-
vention at 34-36 weeks was planned prior to the fetus
descending into the pelvis, to allow sufficient time for
evaluation of moxibustion prior to the timing of the
ECV. Exclusion criteria included: twin pregnancy, risk of
premature birth, heart or kidney diseases affecting the
mother, placenta previa, history of ante-partum haemor-
rhage, intrauterine growth restriction, hypertensive dis-
ease, isoimmunisation, previous uterine operations,
uterine anomaly, pre-labour rupture of the membranes,
multiple pregnancy, fetal congenital abnormality, contra-
indication to vaginal delivery and fetal death in utero.
Randomisation was computer generated, and concealed
in opaque sealed envelopes. Women were allocated to a
study group moxibustion plus usual care or usual care
alone by the research midwife taking the next sequen-
tially numbered envelope.
The treatment protocol was developed by CS a qualified
acupuncturist with 15 years experience of treating women
with acupuncture during pregnancy. The protocol was
based on the review of interventions reported in a
systematic review [15], and Debra Betts an experienced
acupuncture clinician (personal communication September
2009). Women allocated to moxibustion were requested to
attend (with their partner/support person if available) for a
training and demonstration session by the research mid-
wife. This involved advice and demonstration on how
to use the moxibustion safely, and instructions on its use
at home. The woman or her partner/support person
was trained to light the moxibustion sticks and to hold an
individual stick one thumb width above the acupuncture
point BL67 (located on the lateral side of the 5th toe) over
individual feet consecutively. Smokeless and odourless
moxibustion sticks were used. Advice on the intensity of
stimulation was given advising the participant not to let
the points become uncomfortably hot. Participants were
requested to perform this treatment for 10 minutes on
each foot with a total of 20 minutes per treatment, twice a
day (one in the morning and one in the evening at a time
suitable for the participant) for ten days. The participant
was given a ten-day supply of moxibustion sticks. Women
allocated to the control group received usual antenatal
care. Antenatal care for women during this period involved
weekly visits with midwives and obstetricians as per
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with a breech presentation for example on postural sup-
port, although individual clinicians may provide advice to
women. All participants were required to return to the
research midwife 10 days following randomisation for
monitoring. A repeat ultrasound was undertaken to con-
firm the position of the baby for all participants. If the
follow up ultrasound confirmed a breech presentation
women had the option for an ECV.
Data collection and analysis
Clinical outcomes included cephalic presentation at birth,
the need for ECV, mode of birth, perinatal morbidity and
mortality, maternal complications, and adverse events. We
collected data on the numbero fe l i g i b l ew o m e nw i t ha
breech presentation at 34-36 weeks, willingness of partici-
pants to be randomised, women’s views on participation
in the trial, response rates to questionnaires, compliance
with the intervention and aimed to estimate the effect size
for a fully powered trial. The research midwife collected
baseline data on clinical, demographic and socio-economic
characteristics. Women completed a self report question-
naire after each moxibustion session on fetal movement,
and uterine contractions. Following completion of the
intervention participants were asked to complete questions
on the acceptability of the trial.
Sample size and analysis
This was a feasibility study, and it was estimated that a
sample of 30 women would be sufficient to provide data
to answer our study questions. Clinical outcome data
were analysed using ‘an intention to treat’ approach, and
the initial analysis examined the demographic and base-
line characteristics of women randomised to the trial. For
differences between groups testing of categorical data
w a su n d e r t a k e nu s i n gF i s h e r se x a c tt e s t sa n dTt e s t sf o r
continuous data, relative risks and 95% confidence inter-
vals were reported. Levels of significance were reported
at p < 0.05. Descriptive statistics were used to assess the
feasibility questions. Analysis was performed blind to
study group by a study statistician.
Interviews with health professionals
To examine the views of health professionals towards the
acceptability of moxibustion, and views on the RCT we
interviewed participants. We planned to undertake a
minimum of 15 interviews, using a purposive and snow-
ball sample of health professionals to achieve opinions
from both the midwives and doctors. Flyers were distrib-
uted in the antenatal clinics and personal approaches
made to clinical staff to recruit participants to the inter-
views. The interviews were undertaken by CD a junior
research assistant. The interviews typically explored the
participant’s views towards moxibustion, complementary
and alternative medicine (CAM) and the feasibility study.
Each interview was digitally recorded. Interviews were
transcribed verbatim by CD and checked for transcrip-
tion accuracy. Each transcript was read separately and
independently by CD and CS. Data was subject to a pro-
cess of coding and thematic analysis based on notions of
consistency, commonality and the function and effects
for thematic analysis [19]. The research approach was
mostly inductive where the common patterns came from
the data. The data was subjected to coding after repeated
readings of the whole transcript to stay close to the data
and maintain the context. To begin with data was subject
to open coding to identify first order concepts, and then
axial coding to develop categories. Categories were devel-
oped including: keeping birth normal, increasing
women’s choices, establishing the evidence base, and the
need for safety and effectiveness.
Results
Between December 2009 and June 2010, 68 women with
a breech presentation were approached to participate in
the study between, 57% met the entry criteria. Twenty
nine women did not meet the entry criteria. This
included 13 women confirmed with a cephalic presenta-
tion, nine with a gestational age of greater than 36.3,
three not booked with the hospital, and four with medical
conditions. Eleven women declined to participate in the
study, including two too busy, five refused randomisation,
two had pre booked ECV or elective caesarean section,
and two were not interested in the intervention. Recruit-
ment was slower than anticipated and was stopped once
20 women had been randomised (Figure 1).
Outcome data
Clinical outcome data was available for all women. Base-
line characteristics of study participants are presented in
Table 1, and were mostly similar between groups. Most
women were Caucasian, nulliparous, employed, had com-
pleted tertiary education, and were at a gestational age of
35 weeks.
Analyses on clinical outcomes are presented in Table 2.
Five infants in the moxibustion group were cephalic at
delivery (includes before ECV and following successful
ECV), compared with one in usual care only (RR 5.0, 95%
confidence interval (CI) 0.70-35.5, p = 0.11). Two women
in the moxibustion group had cephalic version from ECV
compared with no women in usual care only group (RR
5.0, 95% CI 0.27-95.62, p = 0.28). The position of the pla-
centa at trial entry was examined for women with cephalic
presentation and four women with cephalic presentation
had a placenta in a posterior position. Six women in the
moxibustion group had a caesarean delivery compared
with nine in usual care (RR, 0.67, 95% CI 0.39-1.15, p =
0.15). There were three cases of preterm birth in the
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group. None of these infants had Apgar scores < 7 at
5 minutes, and two infants from the moxibustion group
were admitted to intensive care. One infant was admitted
to intensive care for two days for respiratory support and
one infant for seven days with intrauterine growth restric-
tion and a possible fetal anomaly.
Caesarean delivery was selected as the primary out-
come for a sample size calculation for a future trial. Due
to small numbers from this study a more conservative
estimate 10% effect size was made. To be able to detect
a 10% reduction in caesarean section rate for breech
presentation with an alpha of 0.05 powered at 80% 173
women per arm would be required in a two arm trial.
Assessed for eligibility
n=68
Randomised
n=20
Treatment Group
Allocated to moxibustion n=10
Discontinued intervention n=0
Analysed n=10
Control group
Allocated to usual care n=10
Discontinued intervention n=0
Analysed n=9
Lost to follow up 
n=1
Excluded n=48
Did not meet inclusion criteria n=29
Declined n=11
Other n=8
Figure 1 Flow of participants through the trial.
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the trial will require 381 participants. Based on 15%
of babies at term are in a breech position, and a
recruitment rate of 29% a multi-centre site of 4-5 cen-
tres would be needed.
Acceptability of the intervention
Ten women in the moxibustion group and one woman in
the usual care group completed the questionnaire
describing women’s views on the acceptability of the trial.
Eight women in the moxibustion group and nine women
in the control said they would agree to participate in the
study again if presented with this option. One women in
the moxibustion group reported she was more anxious
about her health and her baby’ health. Women receiving
moxibustion found it acceptable. No women described
moxibustion as painful and there were no reported side-
effects, although two women reported that it was ‘hard to
judge’. Three women found difficulties with administer-
ing the moxibustion, and would have appreciated addi-
tional guidance. However compliance with the treatment
protocol was good with 93% compliance with twice daily
administration. One woman commented she was too
busy to comply with the requested schedule. Fetal move-
ments were collected daily by women in the moxibustion
group only and were reported as more than usual by 5
women, 3 women reported fetal movements as usual and
2 reported no other specific changes. There were few
reports of uterine contractions following treatment, with
one woman per session reporting some contractions or
strong contractions.
Analysis of interviews with health professionals
Nineteen health professionals agreed to participate in
the interviews (one midwife agreed to participate at a
l a t e rd a t eb u tw a su n a b l et ob ec o n t a c t e d ) .T h r e e
Table 1 Baseline characteristics of women at trial entry
Moxibustion Control
N=1 0 % N=1 0 %
Age (years) 30.36 (±3.13) 24.60 (±5.23)
Parity 0 7 70.0 9 90.0
Marital status: Married/defacto 9 90.0 8 80.0
Employment status
Working 6 60.0 4 40.0
Unemployed 1 10.0 2 20.0
Home duties/student 3 30.0 4 40.0
Education*
Completed High school 1 11.1 0 0.0
Completed tertiary education 8 88.9 8* 88.9
Ethnicity
Caucasian 10 100.0 9 90.0
Asian 0 0.0 1 10.0
Gestational age (weeks) 34.8 (±0.69) 35.6 (±0.70)
Type of breech
Complete 1 10.0 2 20.0
Frank 3 30.0 3 30.0
Unknown 6 60.0 5 50.0
Engagement of presenting part
Yes 1 10.0 0 0.0
No 9 90.0 10 100.0
Placental location
Anterior 5 50.0 1 10.0
Posterior 4 40.0 6 60.0
Other 1 10.0 3 30.0
* missing data Data are n and % or mean and standard deviation.
Table 2 Comparison of Outcome Measures Between Moxibustion and Control
Moxibustion (as referent) Control Relative Risk (95% CI) P value
N=1 0 N=1 0
Cephalic presentation (at delivery or before ECV) 2 (20.0) 0 (0) 5.0 (0.27-92.62 0.28
Cephalic presentation at delivery (including successful ECV) 5 (50.0) 1 (10.0) 5.0 (0.70-35.5) 0.11
ECV
Attempted 4 (40.0) 6 (60.0) 0.67 (0.27-1.66) 0.38
Successful* 2 (20.0) 0 (0.0) 5.0 (0.27-95.62) 0.28
Mode of delivery
Vaginal 4 (40.0) 1 (10.0) 4.0 (0.54-29.8) 0.18
Caesarean 6 (60.0) 9 (90.0) 0.67 (0.39-1.15) 0.15
Other outcomes
Preterm birth requiring hospitalisation 2 (20.0) 0 (0) 5.0 (0.27-92.62) 0.28
Prelabour rupture of membranes at < 37 weeks 3 (30.0) 0 (0) 7.0 (0.41, 120.16) 0.18
Gestational age at delivery 38.7 (2.11) 39.9 (3.68) 0.43
Apgar score < 7 at 5 min 0 (0) 0 (0) N/A
Birthweight (g) 3224 (653.9) 3193 (674) 0.92
Admission to NICU 2 (20.0) 0 (0) N/A
Data are n (%) or mean (standard deviation) unless otherwise specified.* Calculated among women attempting ECV.
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general practitioner, and 15 were midwives. Six were
aged 36-45 years and 10 aged in the 46-55 years. Partici-
pants reported an awareness to or personal use of CAM.
Ten midwives had personally used CAM. CAM modal-
ities most frequently used included acupuncture, osteo-
pathy, chiropractic, supplements, herbs, and massage.
On the other hand, no doctors reported previous CAM
use. Thirteen participants were unfamiliar with any lit-
erature on the clinical application of moxibustion for
cephalic presentation.
Eighteen participants expressed positive views towards
the use of CAM in general, and described a place for
CAM in mainstream health care. The following partici-
pant’s comments reflect their belief systems, perceived
gaps in clinical effectiveness, and a responsibility to
ensure new treatments are safe and effective.
I think it’s fantastic, I would love to see eastern and
western philosophies much more combined. I really
obviously like traditional medicine, um, and it would
be great if western medicine was more accepting of
traditional medicine, in a really safe way obviously.
(midwife)
I think we should access it more often. Let’sm o v e
away from the pharmacological medicine, we are
interfering too much. (midwife)
Others expressed more neutral views towards CAM
which reflected a lack of awareness rather than an opi-
nion unsupportive of CAM.
Um, I was probably initially quite um, sceptical, only
because I’ve never seen it done probably, so it’sm o r e
of a bias because I’ve never seen it. (midwife)
Participants’ also spoke of CAM being beneficial to
mainstream medicine and in the treatment of pregnancy
related conditions.
Generally it’s a favourable one because sometimes
women get very frustrated with orthodox medicine
and to deal with the discomforts of pregnancy so uh,
I’m generally favourable towards complementary
medicine because at least it represents some step that
they could take to alleviate whatever is their pro-
blem. Or to deal with whatever challenges they are
facing in the pregnancy. (doctor)
The views expressed towards moxibustion are reported
under three main themes; need for evidence based
research, increasing women’s choices and normalising
birth.
The need for evidence based research
All doctors and midwives emphasised the need for evi-
dence based research to support the future practice of
moxibustion as an adjunct to usual care. Some participants
expressed a view that they could not suggest the use of
moxibustion or any other CAM without such research.
It h i n ki t ’s an adjunct and it has probably a lot of
potentials and possibilities and this trial is part of a
very useful way of ascertaining that. (midwife)
Other participants were positive towards moxibustion
and CAM, although they expressed caution and
described the need for safe practice.
Probably my biggest view would be that its evaluated
and researched so that its evidence based, um in par-
ticularly if it’s a medication therapy or even with
moxibustion that its evidence based that shows that
its not harmful, that there’s nothing harmful that
we’re doing. (midwife)
The one concern I suppose is complacency surrounding
uh the safety of such medicines generally because the
substances are known relatively inert substances. So
that’s my only concern. Uh, as far as effective goes, I
sometimes get a perception that the claims of effective-
ness are overstated and so particularly when something
is starting to become more common, and I know the
evidence is limited, I’m very keen to see the evidence is
assured so that um, we don’t hand down ineffective
things. (doctor)
Participants expressed a common view that moxibus-
tion should be used with caution in pregnancy. They
stressed in the absence of safety data, moxibustion and
other complementary therapies could cause harm to the
mother and baby if not used properly, and women
needed to be aware of the side effects with regard to
dosing.
Y o uj u s tn e e dt om a k es u r et h a ti t ’s alright and
doesn’t affect the baby, that’s the only thing.
(midwife)
I just think that with any kind of medicine it needs
to be done with caution and to make sure that it’s
right for the individual person, what works for one
person might not work for another person in the
s a m ew a y .S oIj u s tt h i n ki t ’s really important that
women understand that just because its complemen-
tary medicine, it doesn’t mean that it still can’tb e
damaging. They need to be very aware that you
know, there are possible side-effects with that as well.
(midwife)
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own professional practice. Clinicians described they did
not know enough about moxibustion and CAM, and
acknowledged that they were not qualified to recom-
mend any form of CAM use to their patients, and doing
so was outside of their scope of practice.
We’re not allowed, we’re not qualified really to advise
on anything really, we just point women in the area of
the research, and that is that, um unless we’re an aro-
matherapist or a fully qualified a reflexologist etc etc.
We can talk to women about natural remedies and
complementary therapies in a broad text but we’re
really not permitted to talk about specifics. (midwife)
Increasing women’s choices
Midwives viewed moxibustion as having the potential to
provide increased choices for women with breech presen-
tation. Participants recalled the experience of stress and
helplessness among women presenting with a breech pre-
sentation, and recalled women would try anything they
could to achieve a normal birth. They felt that women
should look at all options and moxibustion was a reason-
able one to try as it was non-invasive and easy to use.
I guess giving them an opportunity to have another
choice again of the possibility of turning this baby with
moxibustion rather than an ECV or whatever, and
again, you know its all about choice and I’ma l lf o r
giving these women choices, lots of them, so that ulti-
mately they can make a decision they can be happy
with. (midwife)
Normalising birth
Increasing women’s choices was closely related to the
theme of normalising birth. Participation in the trial was
perceived to offer women a potential benefit of having a
vaginal birth. Women were thought to be accepting of
the study as it enabled them to have the feeling of being
in control with their pregnancy, giving them hope and
maintaining positive thinking.
It h i n ki t ’s a very reasonable option to offer women, um
and I believe that they should look at all options to get
the outcome that they want. Ideally being a healthy
experience and a normal birth. Um, and if complemen-
tary medicine can help them in assisting/achieving that
then I think its reasonable for them to have that as one
of their options. (midwife)
Although moxibustion was discussed as a possible
intervention to normalise birth there was some concern
about raising the topic of breech presentation with preg-
nant women at a time when they would not usually
think about it. According to hospital protocols women
were told that breech presentation was normal before
36 weeks and they would not be scanned for breech
presentation before 36 weeks.
...at 34 weeks if we have a breech we are still telling
people that its still quite normal and then all of a
sudden you’re initiating an intervention so your actu-
ally, your actions are saying is that it is abnormal
and we need to treat it, when in actual fact you
know its not the message that we’d like to give.
(midwife)
Evaluating moxibustion in a clinical trial
Participants thought recruitment would be challenging
due to the narrow window to recruit, administer the
intervention and potential ECV if required and infre-
quent visits to the hospital at this stage of their preg-
nancy. There was also concern that detecting a breech
presentation before 36 weeks was not a requirement in
clinical practice and a loss of skill in this area may lead to
missed breech presentations.
The very small window of opportunity being two
weeks. So if missed on one visit then the woman is
usually another 1-2 weeks before she’s seen so there’s
just so limited opportunities. (midwife).
Discussion
Our study provides data to warrant further evaluation of
moxibustion in an Australian population to assist with
cephalic version. Clinical outcomes identify trends in
cephalic version at birth and reduced caesarean delivery,
however numbers were small with wide confidence inter-
vals. The study demonstrated acceptability by woman
with moxibustion, randomisation and participation in the
trial, and compliance with completing questionnaires.
Compliance with the moxibustion was acceptable but
highlighted the importance to provide follow up advice
for women in the first few days following the start of the
intervention. Recruitment was slower than planned, with
barriers to recruitment included the low prevalence of
breech at 34 plus weeks, recruitment at one hospital site,
and limited resources to recruit during a small window
with midwifery care being undertaken in the community.
Clinicians were accepting and supportive of this modality
within an evidence based framework, and highlighted
clinicians respect for the wishes of many women to be
provided with increased choices, and for options to
achieve a normal birth. However clinician support was
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to the woman and her baby.
Many women use complementary therapies during
pregnancy [20], although there are no accurate preva-
l e n c ed a t ao nt h eu s eo fm o x i b u s t i o n .E v i d e n c eo fe f f e c -
tiveness remains inconclusive, and clinical trials in
western settings have yet to replicate the positive results
from trials in China. The most recent trial undertaken in
Switzerland found no difference in version between
groups [18], although these findings may have been influ-
enced by an inadequate dose of moxibustion (one session
per day of moxibustion). Our results suggest self admin-
istration of moxibustion for 20 minutes, twice a day was
an acceptable dose and concur with findings by Vas et al
(2009) [15], who found the intervention was acceptable
to women, and was performed with high compliance.
Both trials used smokeless moxa sticks, which avoided
both potential toxicity from the smoke and dislike of the
o d o u r .T h eh i g hc o m p l i a n c es e e ni no u rt r i a lm a yh a v e
also been influenced by the support participants received
from the research midwife.
The effects of moxibustion on fetal movements have
been reported in other studies, and appear related to the
administration of moxibustion. Establishing the safety of
moxibustion is paramount and although no differences in
adverse outcomes were found between groups, there
were three cases of prelabour rupture of membranes in
the moxibustion group. Preterm birth and premature
rupture of membranes have not been widely reported in
other trials, and in the meta-analysis of data from 383
women there were no significant differences in the rate
of premature rupture of membranes in the moxibustion
group (n = 5) versus control (n = 12) [15]. Future trials
may wish to establish a safety monitoring committee to
monitor this outcome.
There is little research exploring the clinician’s perspec-
tive of moxibustion. Our findings were similar to the small
study from the United Kingdom [5]. Both studies highlight
the need for further research, and identified a need to
address practical issues with recruiting women at the opti-
mal gestation with sufficient time to make use of all treat-
ment options. Our study also demonstrated stakeholders
held positive views towards moxibustion and CAM in
general, particularly among midwives. The motivation
underlying positive views towards CAM has been pro-
posed in several studies to be due to an affinity between
the philosophies and principles of CAM and midwifery,
and supporting women’s choice and autonomy [21]. Find-
ings from the clinician interviews may not represent the
views of all clinicians at the host institution or be consid-
ered representative of clinicians elsewhere, however our
findings indicate a supportive research culture for this
topic of study.
The study has several strengths. Firstly, the trial was
randomised thereby reducing selection bias. Secondly,
although there is no consensus to the acceptable method
of administering moxibustion for cephalic version our
study dose suggests our intervention was in the therapeu-
tic range. However, the study does have a number of
limitations. Results should be interpreted with caution due
to the small size. It is possible women who declined ran-
domisation had different characteristics and outcomes to
those randomised and this could be explored in future
research. The self administration of moxibustion may lead
to variability in the results and a future study will need to
consider how variability could be reduced. Findings from
the interviews maybe limited particularly from the small
group of doctors interviewed, although sufficient data
from midwives provides an understanding of the support
and acceptability of moxibustion. Although the aim of the
interviews was to capture a wide range of views, the pur-
posive and snowball sampling approach used to identify
clinicians may have resulted in some clinicians being less
likely to be included [22]. In this case, selection bias may
have occurred during the identification of participants to
favour those with positive views to moxibustion, CAM or
the RCT. Finally, reflexivity or research bias may have
played a role in shaping the results. The research assistant
had come from a CAM background and biased views may
have unknowingly been projected during the interview
p r o c e s s .T h i sm a yh a v ec a u s e dp a r t i c i p a n t st oe x p r e s s
their views in a different way then they normally would.
The findings will influence future decisions concerning
resourcing and planning for a future trial. We consider
randomisation is acceptable, we will explore if the window
for eligibility could be extended, an appropriate sample
size has been determined allowing for attrition, the trial
identified additional and ongoing in-service training to
facilitate recruitment by health professionals and a need to
provide additional attention to women in the intervention
group. There is also a need to include a safety monitoring
committee.
Conclusion
The use of moxibustion administered over a ten day
period has provided promising preliminary results to
justify further research, and design feature to enhance
implementation in a future study have been identified.
An appropriately powered multi-centred study examin-
ing the treatment and cost effectiveness is now planned.
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